Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 25 mg - capsule, hard - excipient ingredients: purified talc; titanium dioxide; gelatin; pregelatinised maize starch; sodium lauryl sulfate; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 300 mg - capsule, hard - excipient ingredients: gelatin; purified talc; sodium lauryl sulfate; purified water; titanium dioxide; pregelatinised maize starch; iron oxide red; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 300 mg - capsule, hard - excipient ingredients: gelatin; purified talc; pregelatinised maize starch; titanium dioxide; iron oxide red; sodium lauryl sulfate; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: gelatin; titanium dioxide; iron oxide red; sodium lauryl sulfate; purified talc; purified water; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: gelatin; pregelatinised maize starch; titanium dioxide; purified talc; iron oxide red; sodium lauryl sulfate; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 25 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; purified water; purified talc; gelatin; titanium dioxide; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 150 mg - capsule, hard - excipient ingredients: titanium dioxide; gelatin; purified talc; sodium lauryl sulfate; purified water; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 150 mg - capsule, hard - excipient ingredients: gelatin; sodium lauryl sulfate; purified water; titanium dioxide; purified talc; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

European Union - English - EMA (European Medicines Agency)

mylan pharmaceuticals limited - aripiprazole - schizophrenia; bipolar disorder - psycholeptics - aripiprazole mylan pharma is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.aripiprazole mylan pharma is indicated for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.aripiprazole mylan pharma is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in bipolar i disorder in adolescents aged 13 years and older.

European Union - English - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - atosiban (as acetate) - premature birth - other gynecologicals - atosiban is indicated to delay imminent pre-term birth in pregnant adult women with:regular uterine contractions of at least 30 seconds’ duration at a rate of ≥ 4 per 30 minutes;a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%;a gestational age from 24 until 33 completed weeks;a normal foetal heart rate.